Is InfuSystem Holdings, Inc. (INFU) a Buy, Sell, or Hold?
InfuSystem Holdings, Inc.
AMEX:INFU
$9.01 USD
-$0.18 (-1.96%)
- Volume
- 98.27K
- Average Volume
- 222.58K
- Market Capitalization
- $181.84M
- P/E Ratio
- 23.69
- Dividend Yield
- 0.00%
- Price Target
- $15.00
- Year High
- $11.04
- Year Low
- $5.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.14
Industry, Sector & symbol
| Stock Exchange | AMEX |
| CEO | Carrie A. Lachance |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Current Symbol | INFU |
| CUSIP | 45685K102 |
| CIK | 0001337013 |
| Web | https://www.infusystem.com |
| Phone | 248 291 1210 |
| Currency | USD |
| Employees | 502 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.39 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.14 |
| Quick Ratio | 1.80 |
| Cash Ratio | 0.12 |
Sales & Book Value
| Annual Sales | $143.44M |
| Price / Sales | 1.28 |
| Cash Flow | 0.95 |
| Price / Cash Flow | 9.43 |
| Price / Book | 3.10 |
Price Target and Rating
| Average Stock Price Forecast | $15.00 |
| High Stock Price Forecast | $15.00 |
| Low Stock Price Forecast | $15.00 |
| Forecast Upside/Downside | -39.93% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 3 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $0.31 |
| Trailing P/E Ratio | 23.69 |
| PEG Ratio | 0.14 |
| P/E Growth | 0.14 |
| Net Income | $6.63M |
| Net Margin | 5.56% |
| Pretax Margin | 8.28% |
| Return on Equity | 14.00% |
| Return on Assets | 8.02% |
Financials Score
| AltmanZ Score | 4.07 |
| Piotroski Score | 8.00 |
| Working Capital | 19.52M |
| Total Assets | 98.66M |
| Ebit | 12.63M |
| Market Cap | 187.69M |
| Total Liabilities | 39.91M |
Poll Results
About InfuSystem Holdings, Inc. (AMEX:INFU) Stock
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medic ... al equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
2026-06-29 10:40:33
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
InfuSystems Holdings (INFU) Soars 11.1%: Is Further Upside Left in the Stock?
2026-06-29 06:46:08
InfuSystems Holdings (INFU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
InfuSystem: A Good Time To Buy Before A Potential Breakout
2026-06-23 01:46:23
InfuSystem is rated a buy, leveraging a stable oncology-focused patient services segment with strong FCF yields, margin progress, and reasonable valuations. INFU offers an attractive FCF yield of 11.6%, nearly double its peer Viemed Healthcare, and trades at a reasonable forward EV/EBITDA multiple below 6.5x. Management's future financial outlook is supported by reduced Capex, ERP-driven efficiencies, and growth in low-capital-intensive segments like wound care.
Should Value Investors Buy InfuSystems Holdings (INFU) Stock?
2026-06-12 10:41:12
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Does InfuSystems Holdings (INFU) Have the Potential to Rally 62.61% as Wall Street Analysts Expect?
2026-06-05 10:57:13
The consensus price target hints at a 62.6% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is Why Growth Investors Should Buy InfuSystems Holdings (INFU) Now
2026-06-04 13:45:56
InfuSystems Holdings (INFU) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
2026-05-27 10:40:30
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes InfuSystems Holdings (INFU) a New Buy Stock
2026-05-21 13:02:07
InfuSystems Holdings (INFU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Frequently Asked Questions
-
What is the current InfuSystem Holdings, Inc. (INFU) stock price?
-
InfuSystem Holdings, Inc.(AMEX:INFU) stock price is $9.01 in the last trading session. During the trading session, INFU stock reached the peak price of $11.04 while $5.38 was the lowest point it dropped to. The percentage change in INFU stock occurred in the recent session was --1.96% while the dollar amount for the price change in INFU stock was -$0.18.
-
INFU's industry and sector of operation?
-
The AMEX listed INFU is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of INFU?
-
Jerod Funke | Executive Vice President & Chief HR Officer
Barry G. Steele | Executive Vice President & Chief Financial Officer
Carrie Lachance | President, Chief Executive Officer & Director
Addam Chupa | Executive Vice President & Chief Information Officer
Jeanie Latz | Corporate Secretary -
How many employees does INFU have?
-
Number of INFU employees currently stands at 502. INFU operates from 3851 West Hamlin Road, Rochester Hills, MI 48309, US.
-
Link for INFU official website?
-
Official Website of INFU is: https://www.infusystem.com
-
How do I contact INFU?
-
INFU could be contacted at phone #248 291 1210 and can also be accessed through its website. INFU operates from 3851 West Hamlin Road, Rochester Hills, MI 48309, US.
-
How many shares of INFU are traded daily?
-
The average number of INFU shares traded daily for last 3 months was 222.58K.
-
What is the market cap of INFU currently?
-
The market value of INFU currently stands at $181.84M with its latest stock price at $9.01